Results 101 to 105 of about 19,563 (105)

Meropenem/Vaborbactam—A Mechanistic Review for Insight into Future Development of Combinational Therapies

open access: yesAntibiotics
Beta-lactam antibiotics have been a major climacteric in medicine for being the first bactericidal compound available for clinical use. They have continually been prescribed since their development in the 1940s, and their application has saved an ...
Trae Hillyer, Woo Shik Shin
doaj   +1 more source

Cefiderocol in the Successful Treatment of Complicated Hospital-Acquired K. pneumoniae NDM, OXA48 Intraabdominal Infection

open access: yesInfection and Drug Resistance
Ignacy Tarski,1 Jakub Śmiechowicz,2 Wiesława Duszyńska2 1Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland; 2Department and Clinic of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Wroclaw ...
Tarski I, Śmiechowicz J, Duszyńska W
doaj  

Carbapenem-Resistant Gram-Negative Bacteria: Mechanisms, Pathogen-Specific Strategies

open access: yesInfection and Drug Resistance
Xiangquan Li,1,* Xing Tang,2,* Huafeng Ding,1,* Jiaqiong Li1,21Intensive Care Unit, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, People’s Republic of China; 2Intensive Care Unit, The Xuzhou Clinical College ...
Li X, Tang X, Ding H, Li J
doaj  

TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient

open access: yes
TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant ...
Mularoni, Alessandra   +8 more
core   +1 more source

Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms

open access: yesInfectious Diseases and Therapy, 2018
Sarah C. J. Jorgensen, Michael J. Rybak
doaj   +1 more source

Home - About - Disclaimer - Privacy